NCCN and Pfizer Quality Improvement Project: Improving the Care of Patients with Metastatic Breast Cancer (mBC) Through Innovative Strategies – Submit Letters of Intent by Monday, June 9, 2025, by 5:00 pm ET
National Comprehensive Cancer Network® (NCCN®) is pleased to announce a collaboration with Pfizer Global Medical Grants & Partnerships (GMGP) to offer a new grant opportunity to support Quality Improvement projects that will advance the delivery of quality care to people with metastatic breast cancer (mBC).
The intent of the RFP is to encourage NCCN Member and non-NCCN Member Institutions in the United States to submit Letters of Intent describing the development of innovative, impactful, scalable, and sustainable quality improvement projects to advance the delivery of quality care to people with mBC.
Letters of Intent must be submitted through the Pfizer portal by 5:00 pm ET on Monday, June 9, 2025. Please direct questions regarding this RFP to Nicole Zion at [email protected] and Lori Carpenter at [email protected] with the subject line, “NCCN Pfizer mBC RFP.”